VERACYTE, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
VERACYTE, INC. (VCYT) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $1.06 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-26
- VERACYTE, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $1.06M, a 179.53% increase from fiscal 2024.
- VERACYTE, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $381.00K, a 48.44% decline from fiscal 2023.
- VERACYTE, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $739.00K, a 60.57% decline from fiscal 2022.
- VERACYTE, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $1.87M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | $1.06M 10-K · filed 2026-02-26 | |
| 2024-12-31 | $381.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | $739.00K 10-K · filed 2026-02-26 | |
| 2022-12-31 | $1.87M 10-K · filed 2025-02-28 | |
| 2021-12-31 | -$5.69M 10-K · filed 2024-02-29 | |
| 2020-12-31 | -$4.88M 10-K · filed 2023-03-01 | |
| 2019-12-31 | -$4.37M 10-K · filed 2022-02-28 | -$4.99M 10-K · filed 2020-02-25 |
| 2018-12-31 | -$256.00K 10-K · filed 2021-02-22 | |
| 2017-12-31 | $994.00K 10-K · filed 2020-02-25 | |
| 2016-12-31 | $1.09M 10-K · filed 2019-02-25 | |
| 2015-12-31 | $789.00K 10-K · filed 2018-02-27 | |
| 2014-12-31 | $672.00K 10-K · filed 2017-03-01 | |
| 2013-12-31 | $355.00K 10-K · filed 2016-03-14 | |
| 2012-12-31 | $284.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |